Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Radiotherapy using high linear energy transfer (LET) radiation results in effectively killing tumor cells while minimizing dose (biological effective) to normal tissues to block toxicity. It is well known that high LET radiation leads to lower cell survival per absorbed dose than low LET radiation. High-linear energy transfer (LET) neutron treatment induces autophagy in tumor cells, but its precise mechanisms in osteosarcoma are unknown. Here, we investigated this mechanism and the underlying signaling pathways. Autophagy induction was examined in gamma-ray-treated KHOS/NP and MG63 osteosarcoma cells along with exposure to high-LET neutrons. The relationship between radiosensitivity and autophagy was assessed by plotting the cell surviving fractions against autophagy levels. Neutron treatment increased autophagy rates in irradiated KHOS/NP and MG63 cells; neutrons with high-LETs showed more effective inhibition than those with lower LET gamma-rays. To determine whether the unfolded protein response and Akt-mTOR pathways triggered autophagy, phosphorylated eIF2α and JNK levels, and phospho-Akt, phosphor-mTOR, and phospho-p70S6 levels were, respectively, investigated. High-LET neutron exposure inhibited Akt phosphorylation and increased Beclin 1 expression during the unfolded protein response, thereby enhancing autophagy. The therapeutic efficacy of high-LET neutron radiation was also assessed in vivo using an orthotopic mouse model. Neutron-irradiated mice showed reduced tumor growth without toxicity relative to gamma-ray-treated mice. The effect of high-LET neutron exposure on the expression of signaling proteins LC3, p-elF2a, and p-JNK was investigated by immunohistochemistry. Tumors in high-LET-neutron radiation-treated mice showed higher apoptosis rates, and neutron exposure significantly elevated LC3 expression, and increased p-elF2a and p-JNK expression levels. Overall, these results demonstrate that autophagy is important in radiosensitivity, cell survival, and cellular resistance against high-LET neutron radiation. This correlation between cellular radiosensitivity and autophagy may be used to predict radiosensitivity in osteosarcoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312646PMC
http://dx.doi.org/10.3390/ijms21113766DOI Listing

Publication Analysis

Top Keywords

high-let neutron
16
unfolded protein
12
protein response
12
neutron exposure
12
autophagy
10
energy transfer
8
tumor cells
8
cell survival
8
neutron treatment
8
khos/np mg63
8

Similar Publications

Role of the TGF-β/SMAD pathway in tumor radioresistance to boron neutron capture therapy (BNCT) in a human cell line of colon adenocarcinoma.

Appl Radiat Isot

August 2025

Centro Oncológico de Medicina Nuclear. Instituto de Oncología "Ángel H. Roffo" (Universidad de Buenos Aires-Comisión Nacional de Energía Atómica), Av. San Martín 5481 (1417), CABA, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Godoy Cruz 2290, (C1425FQB),

BNCT is a radiotherapeutic modality of high LET energy for different solid tumors as colorectal carcinoma (CRC). Although clinical outcomes show advantages of BNCT, tumor recurrence remains a common challenge. Previously we have described the double strand DNA damage response (DDR) produced by BNCT.

View Article and Find Full Text PDF

Biological effects of high-LET irradiation on the circulatory system.

Int J Radiat Biol

April 2025

Biology and Environmental Chemistry Division, Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), Chiba, Japan.

Purpose: High-linear energy transfer (LET) radiation is generally thought to be more biologically effective in various tissues than low-LET radiation, but whether this also applies to the circulatory system remains unclear. We therefore reviewed biological studies about the effects of high-LET radiation on the circulatory system.

Conclusions: We identified 76 relevant papers (24 in vitro, 2 ex vivo, 51 in vivo, one overlapping).

View Article and Find Full Text PDF

From the atomic nucleus to cancer cure: The marvel of BNCT a nuclear physicist views. Achievements and outstanding problems.

Appl Radiat Isot

June 2025

CNEA, Av. Gral Paz 1499, B1650KNA, San Martín, Prov. Buenos Aires, Argentina; Escuela de Ciencia y Tecnología-UNSAM, Martín de Irigoyen 3100, 1650, San Martín, Prov. Buenos Aires, Argentina; CONICET Av. Rivadavia 1917, C1033AAJ, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: an

The interdisciplinary character of the BNCT endeavour is stressed ranging from nuclear physics to most of the natural and exact sciences. Radiobiology studies, carried out with accelerated proton, alpha and Li beams, are used to isolate the relative biological effectiveness of "pure" high LET radiation. Based on the survival curve results, we discuss the question of the use of fixed RBE factors to convert physical doses into equivalent or isoeffective gamma doses.

View Article and Find Full Text PDF

Protection and operational dosimetric quantities for human external exposure have been compared for situations of outdoor exposure to natural background radiation represented by gamma radiation of primordial and cosmogenic radionuclides and by radiations produced by the galactic cosmic rays in the Earth atmosphere. Calculations were performed using the data from publications of the International Commission on Radiation Units and Measurements and the International Commission on Radiological Protection for global geographical grid of marine and terrestrial locations. Using modelled fluence spectra of natural cosmogenic and terrestrial background radiation, the ratios of the protection to operational quantities were calculated, demonstrating the effect of high-LET neutron component on the ratios of effective dose to absorbed dose, air kerma and the operational quantities.

View Article and Find Full Text PDF

The clinical advantage of proton therapy, compared to other types of irradiations, lies in its reduced dose to normal tissue. Still, proton therapy faces challenges of normal tissue toxicity and radioresistant tumors. To combat these challenges, proton boron capture therapy (PBCT) and neutron capture enhanced particle therapy (NCEPT) were proposed to introduce high-LET radiation in the target volume.

View Article and Find Full Text PDF